-
Largest shareholder and CEO Kang Hee-chul executed open market purchases during Apr 2-6, 2026. -
Perceived as a signal of management's confidence and view of undervaluation.
Largest Shareholder & CEO Kang Hee-chul Open Market Purchase
KOSDAQ Filing Information
- Report on Large Shareholding (General)
- Company: GFC Life Science (388610)
- Submission: Heecheol Kang
- Shares: 5,303,709
- Price: 9,490 KRW
- Market Cap: 50.3 B KRW